Why This Seemingly ‘Great Deal’ Pharma Stock Is Contraindicated
With a massive cash balance (and no debt), rapidly growing revenue and earnings, and a well-stocked pipeline, the pharma stock that’s the focus of today’s…
Revenue
What Are Insiders Seeing In This Clinical-Stage Biotech?
The clinical-stage biopharmaceutical company highlighted in today’s article is focused on the development of novel therapies for cardio-metabolic disease, liver disease, ophthalmic disease and cancer…
Marijuana In The Middle: Meet This Powerful Pot Distributor With Big Revenue Projections
Flow Kana is a California-based company that is part of what today’s article notes is “a relatively new form of cannabis business [that] has emerged:…
This Tech Stock Is On Fire. Will Its Hot Streak Continue – Or Will Investors Get Burned?
Having surged over 200% in the past year, the live video streaming (and virtual gift giving) stock highlighted in today’s article – Momo – is…
Growing Like Crazy: Automatic Ticket to Investor Wealth?
“Good and dependable growth is getting hard to find. But a few companies seem to have found the answer.” Today’s article highlights the fact that…